Accessibility Menu
 
Adlai Nortye logo

Adlai Nortye

(NASDAQ) ANL

Current Price$7.15
Market Cap$231.15M
Since IPO (2023)-51%
5 YearN/A
1 Year+235%
1 Month-25%

Adlai Nortye Financials at a Glance

Market Cap

$231.15M

Revenue (TTM)

$6.49M

Net Income (TTM)

$54.06M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$7.15

Volume

13,193

Open

$7.27

Previous Close

$7.15

Daily Range

$6.75 - $7.70

52-Week Range

$0.88 - $12.09

ANL News

No articles available.

ANL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Adlai Nortye

Industry

Biotechnology

Employees

123

CEO

Yang Lu, EMBA

Headquarters

Grand Cayman, KY1-1104, KY

ANL Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-2%

Return on Assets

-73%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$231.15M

Shares Outstanding

31.24M

Volume

13.19K

Short Interest

0.00%

Avg. Volume

959.15K

Financials (TTM)

Gross Profit

$1.87M

Operating Income

$54.90M

EBITDA

$48.08M

Operating Cash Flow

$51.82M

Capital Expenditure

$170.00K

Free Cash Flow

$51.99M

Cash & ST Invst.

$60.91M

Total Debt

$27.23M

Adlai Nortye Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2024YOY CHG

Revenue

$745.00K

N/A

Gross Profit

$745.00K

+215.3%

Gross Margin

100.00%

N/A

Market Cap

$231.15M

N/A

Market Cap/Employee

$1.88M

N/A

Employees

123

N/A

Net Income

$13.81M

+78.2%

EBITDA

$14.36M

+77.1%

Quarterly Fundamentals

Name
Q2 2024YOY CHG

Net Cash

$422.00K

-100.6%

Accounts Receivable

$3.09M

+761.3%

Inventory

$0.00

N/A

Long Term Debt

$257.00K

-45.2%

Short Term Debt

$44.31M

+46.0%

Return on Assets

-72.81%

N/A

Return on Invested Capital

-2.12%

N/A

Free Cash Flow

$14.25M

-70.0%

Operating Cash Flow

$14.19M

-70.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
THARTharimmune, Inc.
$4.07-2.98%
ADAPAdaptimmune Therapeutics plc
$0.05-3.00%
LPCNLipocine Inc.
$7.15-2.19%
APLMApollomics, Inc.
$18.49-3.19%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About ANL

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.